相关实验视频
Updated: May 6, 2026

08:18
A Model of Chronic Nutrient Infusion in the Rat
Published on: August 14, 2013
12.7K
高脂肪饮食,表观遗传学和动脉样硬化:叙述性审查
1Department of Translational Research, Western University of Health Sciences, Pomona, CA 91766, USA.
Nutrients
|January 11, 2025
概括
富含和脂肪酸的高脂肪饮食通过表观遗传重编程导致动脉样硬化. 虽然向表观遗传修饰的药物显示出希望,但需要进一步的研究和临床试验来确认它们在治疗动脉样硬化的有效性.
科学领域:
- 心血管科学 心血管科学
- 营养科学 营养科学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 动脉样硬化是一种慢性炎症性疾病,与高脂血症和高胆固醇血症等危险因素有关.
- 和脂肪酸与此有关,但它们在动脉样硬化病理生理学中的表观遗传作用需要进一步阐明.
- 目前关于动脉样硬化的表观遗传学的研究是有限的,通常侧重于甲基化和基因组修饰抑制剂.
研究的目的:
- 审查高脂肪饮食,表观遗传重编程和动脉样硬化之间的关联.
- 探索分子和细胞机制,将饮食诱导的表观遗传与动脉样硬化发育联系起来.
- 讨论表观遗传干预在治疗动脉样硬化的潜力.
主要方法:
- 使用关键词进行了全面的文献搜索:高脂肪饮食,表观遗传学和动脉样硬化.
- 文章进行了相关性选,并排除了重复和无关的研究.
- 该审查侧重于临床前和临床研究,研究饮食和动脉样硬化中的表观遗传修饰之间的相互作用.
主要成果:
- 高脂肪饮食,特别是富含和脂肪酸的饮食,是动脉样硬化的重要危险因素.
- 表观遗传重编程在饮食和动脉样硬化之间的多因素关联中发挥着关键作用.
- 精确的分子链接和细胞机制仍然不完全理解,需要进一步调查.
结论:
- 高脂肪饮食通过表观遗传重编程和改变基因表达促进动脉样硬化.
- 表观遗传干预在临床前和临床环境中显示出减轻动脉样硬化的潜力,但需要更大的试验来验证.
- 母亲的高脂肪饮食摄入可能会增加后代的心血管疾病风险,强调在怀孕期间需要注意饮食.
相关概念视频
Lipid-derived Compounds in the Human Body
5.5K
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
5.5K
Obesity
1.6K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
Coronary Artery Disease I: Introduction
1.8K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Coronary Artery Disease II: Pathophysiology
1.1K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Atherosclerosis I: Introduction
2.5K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Atherosclerosis III: Management
747
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747

